Small-Cap Guru Chuck Royce is Making Moves in Molex, Nu Skin & More

Chuck Royce, Royce & Associates: The number of Molex Incorporated (NASDAQ:MOLXA)’s Class A shares recently went down in the equity portfolio of Chuck Royce’s hedge fund Royce & Associates. According to a filing with the Securities and Exchange Commission, Royce disclosed ownership of some 1.7 million Molex Class A shares, versus 9.9 million shares of the same class disclosed in the most recent 13F. This is a decline of a little over 82%. At the current price of Molex’s class A stock, the value of the Royce’s position amounts to some $64.1 million. Aside from its class A shares, Royce & Associates also holds around 190,300 shares of Molex’s common stock.

Chuck Royce

At the beginning of September, Molex mentioned it is signing a definitive agreement to be purchased by Koch Industries. Koch Industries offered to buy all outstanding shares of Molex, offering a price of $38.50 per share in cash, with the total value of the transaction amounting to some $7.2 billion. After the deal is completed, Molex will become a standalone subsidiary of Koch, Molex said in a statement. Also in September, Molex reported on the completion of its acquisition of the Germany-based FCT Electronics Group.

Nu Skin

In another filing with the SEC, Royce & Associates disclosed cutting its position in Nu Skin Enterprises, Inc. (NYSE:NUS) to some 4 million shares, from the previously owned 6.9 million shares. The position held by Royce in Nu Skin represents almost 6.9% of the company and have a value of around $393 million.

Children’s Place

Also, Royce & Associates disclosed increasing its position in Children’s Place Retail Stores, Inc. (NASDAQ:PLCE), a separate filing showed. Royce currently owns over 2.2 million shares of Children’s Place, with the value of the stake amounting to some $128.6 million and the position representing 10%  of the company. In the latest 13F, Royce & Associates disclosed ownership of over 1.9 million shares of Children’s Place Retail Stores.

Recommended Reading:

Chuck Royce Bio

Disclosure: none